SCHEMBL3899470

SCHEMBL3899470

O=NNS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1846678 0.60
SCHEMBL10788545 0.59
SCHEMBL1665889 0.59
SCHEMBL15133749 0.56
SCHEMBL13825886 0.56
SCHEMBL218382 0.56
SCHEMBL471026 0.56
SCHEMBL167239 0.54
Ammonia Solution, Strong SCHEMBL5968084 0.53
Hydrochloric Acid SCHEMBL4025651 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150602-B2 Precursor used for labeling hepatorcyte receptor and containing trisaccharide and diamide demercaptide ligand, method for preparing the same, radiotracer and pharmaceutical composition of the same ATOMIC ENERGY COUNCIL, INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2015-10-06 US claimed
US-20140031533-A1 PRECURSOR USED FOR LABELING HEPATORCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DIAMIDE DEMERCAPTIDE LIGAND, METHOD FOR PREPARING THE SAME, RADIOTRACER AND PHARMACEUTICAL COMPOSITION OF THE SAME ATOMIC ENERGY COUNCIL, INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2014-01-30 US claimed
US-10005739-B2 Quinazolinone and isoquinolinone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2018-06-26 US disclosed
EP-2842939-B1 BENZAMIDE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2018-05-30 EP disclosed
US-9695118-B2 Benzamide derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2017-07-04 US disclosed
US-20160272595-A1 QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-09-22 US disclosed
EP-3061749-A1 QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 2016-08-31 EP disclosed
US-9227931-B1 Bifunctional compound and method for manufacturing the same Atomic Energy Council—Institute of Nuclear Energy Research (TW) 2016-01-05 US disclosed
US-9150602-B2 Precursor used for labeling hepatorcyte receptor and containing trisaccharide and diamide demercaptide ligand, method for preparing the same, radiotracer and pharmaceutical composition of the same ATOMIC ENERGY COUNCIL, INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2015-10-06 US disclosed
US-20150152047-A1 BENZAMIDE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2015-06-04 US disclosed
EP-2842939-A1 BENZAMIDE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 2015-03-04 EP disclosed
EP-0630264-B1 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS BIOSYNTHEMA INC (US) 2002-11-06 EP disclosed
EP-0630264-A1 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS MALLINCKRODT MEDICAL, INC. (US) 1994-12-28 EP disclosed
EP-0630264-A1 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS MALLINCKRODT MEDICAL, INC. (US) 1994-12-28 EP disclosed
EP-0630264-A4 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS. MALLINCKRODT MEDICAL INC (US) 1994-10-17 EP disclosed
EP-0630264-A4 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS. MALLINCKRODT MEDICAL INC (US) 1994-10-17 EP disclosed
US-5310536-A Ligands for improving metal chelate formation kinetics MALLINCKRODT MEDICAL, INC. (US) 1994-05-10 US disclosed
US-5310536-A Ligands for improving metal chelate formation kinetics MALLINCKRODT MEDICAL, INC. (US) 1994-05-10 US disclosed
WO-1993015771-A1 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS MALLINCKRODT MEDICAL, INC. (US) 1993-08-19 WO disclosed
WO-1993015771-A1 LIGANDS FOR IMPROVING METAL CHELATE FORMATION KINETICS MALLINCKRODT MEDICAL, INC. (US) 1993-08-19 WO disclosed